Current filters:

Fosun PharmaHematology

1 to 9 of 96511 results

Eylea beats Avastin and Lucentis for visual acuity in DME patients


US biotech firm Regeneron Pharmaceuticals and partner Germany’s Bayer saw their shares leap 8.5% to…

AvastinBayerBiotechnologyEyleaLucentisNovartisOphthalmicsRegeneron PharmaceuticalsResearchRoche

Amgen sues Sanofi and Regeneron over alleged patent infringement


USA-based Amgen has filed a law suit in the US District Court of Delaware against French pharma major…

alirocumabAmgenBiotechnologyCardio-vascularevolocumabLegalPatentsRegeneron PharmaceuticalsSanofiUSA

Horizon Pharma buys US rights to Nuvo’s Pennsaid for $45 million


Canadian specialty drugmaker Nuvo Research says it has completed the sale of its osteoarthritis pain…

Anti-Arthritics/RheumaticsHorizon PharmaLicensingMallinckrodtNuvo ResearchPennsaidPharmaceuticalUSA

Indian government takes action on country’s growing mental health problems


Stigma, ignorance and a severe lack of doctors in India have long marred mental health care projects…

Human InterestIndiaNeurologicalPharmaceutical

GSK Ebola vaccine “too late” for current Ebola outbreak; more on Ebola


UK pharma giant GlaxoSmithKline says any Ebola vaccine it produces will come too late for the current…

Anti-viralsAVI-6002GlaxoSmithKlinePharmaceuticalProductionResearchSarepta Therapeutics

Profectus BioSciences gets US government funding for Ebola vaccine development


Under a one-year contract with US biotech firm Profectus BioSciences, the US Department of Health and…

Anti-viralsBiotechnologyFinancialProfectus BioSciencesResearchUSA

Pharmacyclics’ Imbruvica gains EU approval for two blood cancers


US drugmaker Pharmacyclics has received marketing approval from the European Commission for Imbruvica…

EuropeImbruvicaJohnson & JohnsonOncologyPharmaceuticalPharmacyclicsRegulation

1 to 9 of 96511 results



Back to top